IDA & IBRD total vs Maldives: Prevalence of anemia among women of reproductive age
IDA & IBRD total
32.9%
in 2023
Maldives
43.4%
in 2023
IDA & IBRD total rank
22nd
Maldives rank
21st
Prevalence of anemia among women of reproductive age over time
- IDA & IBRD total
- Maldives
How they compare
Maldives currently reports 43.4% against 32.9% in IDA & IBRD total, a difference of 10.5%.
That makes Maldives's figure about 1.3 times IDA & IBRD total's.
Across all 24 years both countries report, Maldives has been ahead every year.
IDA & IBRD total ranks 22nd and Maldives ranks 21st of 47 groups.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA & IBRD total | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.4% | 45.3% | 13.9% | Maldives |
| 2010s | 30.4% | 44.0% | 13.6% | Maldives |
| 2020s | 32.1% | 43.3% | 11.2% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, IDA & IBRD total or Maldives?
- Maldives, at 43.4% against 32.9% in IDA & IBRD total as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between IDA & IBRD total and Maldives?
- 10.5%, with Maldives ahead.
- How many years of comparable data are there for IDA & IBRD total and Maldives?
- 24 years are reported by both, from 2000 to 2023.
- How do IDA & IBRD total and Maldives rank globally for prevalence of anemia among women of reproductive age?
- IDA & IBRD total ranks 22nd and Maldives ranks 21st of 47 groups.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.